Bristol-Myers Squibb (United States) — United States
Biochemistry, Genetics and Molecular Biology · Life Sciences
15h-index1.5kcitations25works0.52yr avg
Accepting Students?
No reports yet. Know if this professor is taking students?
Research Topics
Cancer therapeutics and mechanisms(15), Synthesis and Biological Evaluation(8), Synthesis and biological activity(6), Bioactive Compounds and Antitumor Agents(5), Protein Degradation and Inhibitors(4)
Publications25 total
Organic Process Research & Development·2025
Organic Process Research & Development·2025· 1 cited
Medicinal Chemistry Research·2022Open Access
ACS Catalysis·2022· 11 citedOpen Access
Nature·2016· 629 cited
Tetrahedron Asymmetry·2015· 22 cited
Bioorganic & Medicinal Chemistry Letters·2012· 57 cited
Bioorganic & Medicinal Chemistry·2011· 28 citedOpen Access
Bioorganic & Medicinal Chemistry·2006· 20 cited
Bioorganic & Medicinal Chemistry·2005· 53 cited
Bioorganic & Medicinal Chemistry Letters·2004· 18 cited
Letters in Drug Design & Discovery·2004· 7 cited
Bioorganic & Medicinal Chemistry·2004· 80 cited
Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug.
PubMed·2003· 95 cited
Bioorganic & Medicinal Chemistry Letters·2003· 12 cited
page 1 of 2Next →
Frequent Co-authors
Leroy F. Liu(14), Angela Liu(12), Edmond J. LaVoie(12), Nai Zhou(9), Tsai‐Kun Li(7), Sudhir Singh(6), Shejin Zhu(4), Gang Lu(3), Gilles Carmel(3), Abhijit Ray(3), Jinming Yang(3), George W. Muller(3), Hon‐Wah Man(3), John R. Coombs(3), Mary E. Matyskiela(2), Takumi Ito(2), Barbra Pagarigan(2), Chin-Chun Lu(2), Karen Miller(2), Wei Fang(2)